A Proteinase 3 Contribution to Juvenile Idiopathic Arthritis-Associated Cartilage Damage

Eric K Patterson1, Nicolas Vanin Moreno1, Douglas D Fraser2,3,4

  • 1Centre for Critical Illness Research, Lawson Health Research Institute, London, ON N6A 5W9, Canada.

Insights

Proteinase 3 (PR3), an enzyme in neutrophils, contributes to juvenile idiopathic arthritis (JIA) joint damage by degrading collagen. This study found PR3 in JIA synovial fluid, acting similarly to leukocyte elastase (HLE) in causing cartilage degradation.

Area of Science:

  • Biochemistry
  • Immunology
  • Rheumatology

Background:

  • Juvenile idiopathic arthritis (JIA) pathogenesis is not fully understood.
  • Leukocyte proteolytic enzymes, such as elastase and cathepsin G, are implicated.
  • The role of proteinase 3 (PR3) in JIA has not been previously evaluated.

Purpose of the Study:

  • To investigate PR3 concentrations in JIA synovial fluid.
  • To assess the cartilage degradation potential of PR3 in vitro.
  • To compare PR3's activity with leukocyte elastase (HLE).

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) for PR3, HLE, and myeloperoxidase (MPO) in synovial fluid.
  • In vitro collagen II hydrolysis assay to measure cartilage degradation by PR3 and HLE.
  • Correlation analysis between analyte concentrations.

Main Results:

  • PR3, HLE, and MPO were detected in JIA synovial fluid at significant concentrations.
  • PR3 demonstrated efficient hydrolysis of collagen II, comparable to HLE.
  • A strong positive correlation was observed between PR3 and HLE concentrations (rs = 0.898).

Conclusions:

  • PR3 is present in JIA synovial fluid and contributes to joint damage.
  • PR3, alongside HLE, plays a role in the cartilage degradation associated with JIA.
  • These findings highlight PR3 as a potential therapeutic target for JIA.